Literature DB >> 23764562

Association of adiponectin (AdipoQ) and sulphonylurea receptor (ABCC8) gene polymorphisms with Type 2 Diabetes in North Indian population of Punjab.

Kawaljit Matharoo1, Punit Arora, A J S Bhanwer.   

Abstract

In Type 2 Diabetes (T2D), adiponectin (AdipoQ) and sulphonylurea receptor genes (ABCC8) are important targets for candidate gene association studies. The single nucleotide polymorphisms (SNPs) in these genes have been associated with features of the metabolic syndrome across various populations. The present case-control study undertaken in the population of Punjab, evaluates the association of +45T>G polymorphism in AdipoQ gene; and Exon16-3C>T as well as Exon18C>T polymorphisms in ABCC8 gene with T2D. These SNPs were genotyped in 200 T2D cases and 200 non-diabetic healthy controls using the PCR-RFLP method. The frequency of the minor G-allele for AdipoQ+45(T>G) polymorphism was significantly higher in T2D cases (29.0%) than in controls (21.5%) [P=0.02, OR=1.49 (1.07-2.04)]. The genetic model analysis revealed that the G-allele cumulatively provides nearly 1.59-1.78 fold increased risk to T2D under the additive (P=0.009; OR=1.59, 1.12-2.25 at 95% CI), dominant (TG/GG vs. TT) (P=0.034, OR=1.64, 1.04-2.56 at 95% CI) and codominant model (TG vs. TT/GG) (P=0.014; OR=1.78, 1.12-2.82 at 95% CI) after adjusting for confounding factors. However, no difference in the distribution of genotype and allele frequencies was observed for both the ABCC8 polymorphisms. The distribution of obesity profiles (BMI, WC and WHR) was also significantly different between cases and controls (P<0.05). Higher BMI and central obesity were observed to increase the risk of T2D. G-allele of +45(T>G) polymorphism in the adiponectin gene appears to be associated with increased risk of T2D, but the polymorphisms in sulphonylurea receptor gene do not seem to be associated with T2D in the population of Punjab.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ABCC8/SUR1; ADA; ANOVA; AdipoQ; Adiponectin; American Diabetic Association; Analysis of Variance; BMI; Body Mass Index; CAD; CI; Confidence Interval; Coronary Artery Disease; DBP; Diastolic Blood Pressure; EDTA; Ethylene diamine tetra acetic acid; HWE; Hardy-Weinberg Equilibrium; IDF; IR; Insulin Resistance; International Diabetes Federation; LD; Linkage Disequilibrium; OR; Odds Ratio; PCR-RFLP; Polymerase Chain Reaction-Restriction Fragment Length Polymorphism; SBP; SD; SNP; SPSS; Single Nucleotide Polymorphism; Standard Deviation; Statistical Package for the Social Sciences; Sulphonylurea receptor; Systolic Blood Pressure; T2D; TZD; Thiazolidinediones; Type 2 Diabetes; WC; WHR\; Waist Circumference; Waist Hip Ratio

Mesh:

Substances:

Year:  2013        PMID: 23764562     DOI: 10.1016/j.gene.2013.05.075

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  10 in total

1.  Association of PGC-1α gene with type 2 diabetes in three unrelated endogamous groups of North-West India (Punjab): a case-control and meta-analysis study.

Authors:  Rubina Sharma; Kawaljit Matharoo; Rohit Kapoor; A J S Bhanwer
Journal:  Mol Genet Genomics       Date:  2017-10-24       Impact factor: 3.291

2.  Association of genetic variants in INS (rs689), INSR (rs1799816) and PP1G.G (rs1799999) with type 2 diabetes (T2D): a case-control study in three ethnic groups from North-West India.

Authors:  Jasmine Sokhi; Ruhi Sikka; Priyanka Raina; Ramandeep Kaur; Kawaljit Matharoo; Punit Arora; Ajs Bhanwer
Journal:  Mol Genet Genomics       Date:  2015-08-07       Impact factor: 3.291

3.  Screening of mitochondrial mutations and insertion-deletion polymorphism in gestational diabetes mellitus in the Asian Indian population.

Authors:  Imran Ali Khan; Noor Ahmad Shaik; Nagarjuna Pasupuleti; Srinivas Chava; Parveen Jahan; Qurratulain Hasan; Pragna Rao
Journal:  Saudi J Biol Sci       Date:  2014-11-12       Impact factor: 4.219

4.  Investigation of Calpain 10 (rs2975760) gene polymorphism in Asian Indians with Gestational Diabetes Mellitus.

Authors:  Imran Ali Khan; Sireesha Movva; Noor Ahmad Shaik; Srinivas Chava; Parveen Jahan; Kamal Kiran Mukkavali; Vasundhara Kamineni; Qurratulain Hasan; Pragna Rao
Journal:  Meta Gene       Date:  2014-04-17

Review 5.  Association between ADIPOQ +45T>G polymorphism and type 2 diabetes: a systematic review and meta-analysis.

Authors:  Yaofu Fan; Kun Wang; Shuhang Xu; Guofang Chen; Hongjie Di; Meng Cao; Chao Liu
Journal:  Int J Mol Sci       Date:  2014-12-30       Impact factor: 5.923

6.  Identification of genetic variants in pharmacogenetic genes associated with type 2 diabetes in a Mexican-Mestizo population.

Authors:  Nidia Samara Rodríguez-Rivera; Patricia Cuautle-Rodríguez; Fernando Castillo-Nájera; Juan Arcadio Molina-Guarneros
Journal:  Biomed Rep       Date:  2017-06-02

7.  Association between +45T>G adiponectin polymorphism gene and type 2 diabetes mellitus and metabolic syndrome in a Venezuelan population.

Authors:  María Patricia Sánchez; Carem Prieto; Endrina Mujica; Kendry Vergara; Enifer Valencia; Eudymar Villalobos; Mayerlim Medina; Michael Parra; Rosanna D'Addosio; Kyle Hoedebecke; Johel E Rodríguez; Valmore Bermudez
Journal:  F1000Res       Date:  2019-03-14

8.  Association of AdipoQ gene variation (rs1501299) and oxidative stress with cardiovascular disease in North West Indian population of Punjabi women.

Authors:  Jyot Amrita; Mridula Mahajan; A J S Bhanwer; Kawaljit Matharoo
Journal:  J Med Biochem       Date:  2021-01-26       Impact factor: 3.402

9.  Associations of ATP-Sensitive Potassium Channel's Gene Polymorphisms With Type 2 Diabetes and Related Cardiovascular Phenotypes.

Authors:  Cheng Liu; Yanxian Lai; Tianwang Guan; Junfang Zhan; Jingxian Pei; Daihong Wu; Songsong Ying; Yan Shen
Journal:  Front Cardiovasc Med       Date:  2022-03-23

10.  Meta-analysis of the association between adiponectin SNP 45, SNP 276, and type 2 diabetes mellitus.

Authors:  Yuwei Dong; Gongping Huang; Xin Wang; Zhaoming Chu; Jingzhi Miao; Houwen Zhou
Journal:  PLoS One       Date:  2020-10-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.